Over the last 5 years, more than 4000 FDA-regulated clinical trials were initiated worldwide for rare disease treatments.
Chris Adams, PhD, MBA
Advertisement
Articles by Chris Adams, PhD, MBA
Advertisement
Latest Updated Articles
The Journey of Commitment to Ultra-Rare Disease Patients: A Supportive Business ModelPublished: August 5th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
3
Breaking News: CVS Buys Rite Aid, Bartell Drugs
4
Current and Emerging BCMAxCD3 Bispecifics
5
